This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by HARRISON, D. C. Articles by ROSS, J. Search for Related Content PubMed PubMed Citation Articles by HARRISON, D. C. Articles by ROSS, J., JR.

(Circulation. 1964;29:84.)
© 1964 American Heart Association, Inc.

---

Effects of Beta Adrenergic Blockade on the Circulation, with Particular Reference to Observations in Patients with Hypertrophic Subaortic Stenosis

DONALD C. HARRISON M.D.¹; EUGENE BRAUNWALD M.D.¹; GERALD GLICK M.D.¹; DEAN T. MASON M.D.¹; CHARLES A. CHIDSEY M.D.¹; JOHN ROSS JR. M.D.¹

¹ From the Cardiology Branch, National Heart Institute, Bethesda, Maryland.

The circulatory effects of blocking the beta adrenergic receptors with Nethalide were studied in 10 patients with hypertrophic subaortic stenosis and in five postoperative subjects undergoing right heart catheterization. In the resting state, the heart rate and the rate of pressure development in the right ventricle diminished slightly, but cardiac index was not altered by the administration of Nethalide. These observations suggest that tonic sympathetic activity is not of major importance in basal subjects in the supine position. Nethalide attenuated the increase in heart rate and right ventricular dp/dt associated with exercise, and abolished the response of these two variables to the administration of isoproterenol. In the patients with hypertrophic subaortic stenosis Nethalide had little effect on the severity of the obstruction at rest, but reduced the intensification of the obstruction produced by exercise or isoproterenol. The possible clinical benefits of blocking the beta adrenergic receptors in these patients were discussed.

This article has been cited by other articles:

				E. Braunwald Adventures in Cardiovascular Research Circulation, July 14, 2009; 120(2): 170 - 180. [Abstract] [Full Text] [PDF]

				M. A. Fifer and G. J. Vlahakes Management of Symptoms in Hypertrophic Cardiomyopathy Circulation, January 22, 2008; 117(3): 429 - 439. [Full Text] [PDF]

				M. S. Maron, I. Olivotto, A. G. Zenovich, M. S. Link, N. G. Pandian, J. T. Kuvin, S. Nistri, F. Cecchi, J. E. Udelson, and B. J. Maron Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction Circulation, November 21, 2006; 114(21): 2232 - 2239. [Abstract] [Full Text] [PDF]

				M. V. Sherrid, I. Barac, W. J. McKenna, P. M. Elliott, S. Dickie, L. Chojnowska, S. Casey, and B. J. Maron Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1251 - 1258. [Abstract] [Full Text] [PDF]

				M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction Ann. Thorac. Surg., February 1, 2003; 75(2): 620 - 632. [Abstract] [Full Text] [PDF]

				L.J. Kappenberger, C. Linde, X. Jeanrenaud, C. Daubert, W. McKenna, E. Meisel, N. Sadoul, L. Chojnowska, L. Guize, D. Gras, et al. Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy Europace, January 1, 1999; 1(2): 77 - 84. [Abstract] [PDF]

				M. V. Sherrid, G. Pearle, and D. Z. Gunsburg Mechanism of Benefit of Negative Inotropes in Obstructive Hypertrophic Cardiomyopathy Circulation, January 13, 1998; 97(1): 41 - 47. [Abstract] [Full Text] [PDF]

				E. Braunwald Induced Septal Infarction : A New Therapeutic Strategy for Hypertrophic Obstructive Cardiomyopathy Circulation, April 15, 1997; 95(8): 1981 - 1982. [Full Text]

				P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF]

				E. D. Wigle, H. Rakowski, B. P. Kimball, and W. G. Williams Hypertrophic Cardiomyopathy : Clinical Spectrum and Treatment Circulation, October 1, 1995; 92(7): 1680 - 1692. [Full Text]

				D. R. ROSING and S. E. EPSTEIN Verapamil in the Treatment of Hypertrophic Cardiomyopathy Ann Intern Med, May 1, 1982; 96(5): 670 - 672. [Abstract] [PDF]

				A. G. ADELMAN, E. D. WIGLE, N. RANGANATHAN, G. D. WEBB, B. S. L. KIDD, W. G. BIGELOW, and M. D. SILVER The Clinical Course in Muscular Subaortic Stenosis: A Retrospective and Prospective Study of 60 Hemodynamically Proved Cases Ann Intern Med, October 1, 1972; 77(4): 515 - 525. [Abstract] [PDF]

				N. J. Demos, J. J. Timmes, G. E. Levinson, A. B. Weisse, and C. B. Moschos Five Year Follow-Up of Subaortic Muscular Stenosis Treated By Right Ventricular Septectomy Vascular and Endovascular Surgery, September 1, 1969; 3(3): 138 - 143. [PDF]

				S. E. EPSTEIN and E. BRAUNWALD The Effect of Beta Adrenergic Blockade on Patterns of Urinary Sodium Excretion: Studies in Normal Subjects and in Patients with Heart Disease Ann Intern Med, July 1, 1966; 65(1): 20 - 27. [Abstract] [PDF]